The conference will cover drug and treatment updates with a focus on precision medicine, gynecological malignancies, hematologic malignancies, prostate, bladder cancer and GI malignancies. The conference features a comprehensive review of new drugs approved along with their mechanism of action, and a keynote lecture, Stand Up to Cancer focusing on developmental therapeutics. Next generation studies will also be addressed, and the conference will offer participants a session designed to provide insight into the latest advances in lung cancer treatment, including integration of new molecularly-targeted therapies and immunotherapy.

URLs:

Twitter: https://go.evvnt.com/2523190-2?pid=91 

LinkedIn: https://go.evvnt.com/2523190-3?pid=91 

Prices:

Physicians: USD 125.00,

All Other Healthcare Providers: USD 100.00,

Residents/Fellows/Medical Students: USD 0.00,

CSHS Advanced Practice Providers/Researchers/Administration: USD 0.00,

Industry: USD 225.00

Speakers: John Chute, MD, Robert A. Figlin, MD, Karen Reckamp, MD